BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30192720)

  • 1. All-Cause Mortality for Life Insurance Applicants with a Family History of Coronary Artery Disease Before 60.
    Freitas SA; MacKenzie R; Wylde DN; Von Bergen J; Holowaty JC; Beckman M; Rigatti SJ; Gill S
    J Insur Med; 2018 Jan; 47(3):159-171. PubMed ID: 30192720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-Cause Mortality for Life Insurance Applicants with the Presence of Bundle Branch Block.
    Freitas SA; MacKenzie R; Wylde DN; Von Bergen J; Holowaty JC; Beckman M; Rigatti SJ; Zamarripa D; Gill S
    J Insur Med; 2019; 48(1):36-47. PubMed ID: 31219368
    [No Abstract]   [Full Text] [Related]  

  • 3. All-Cause Mortality for Life Insurance Applicants with a History of Prostate Cancer.
    Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Beckman M; Rigatti SJ; Gill S
    J Insur Med; 2017; 47(2):95-106. PubMed ID: 29490159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-Cause Mortality for Life Insurance Applicants with a History of Breast Cancer.
    Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Hart A; Rigatti SJ; Gill S
    J Insur Med; 2017; 47(1):6-22. PubMed ID: 28836905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-Cause Mortality for Diabetics or Individuals with Hyperglycemia Applying for Life Insurance.
    Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Hart A; Rigatti SJ; Gill SJ
    J Insur Med; 2016; 46(1):2-12. PubMed ID: 27562107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scoring life insurance applicants' laboratory results, blood pressure and build to predict all-cause mortality risk.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2012; 43(3):169-77. PubMed ID: 23451618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NT-proBNP as a predictor of all-cause mortality in a population of insurance applicants.
    Clark M; Kaufman V; Fulks M; Dolan VF; Stout RL
    J Insur Med; 2014; 44(1):7-16. PubMed ID: 25004594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Carcinoembryonic Antigen with Mortality in an Insurance Applicant Population.
    Rigatti SJ; Stout R
    J Insur Med; 2019; 48(1):24-35. PubMed ID: 31747325
    [No Abstract]   [Full Text] [Related]  

  • 9. Familial premature coronary artery disease mortality and obstructive sleep apnea.
    Gami AS; Rader S; Svatikova A; Wolk R; Herold DL; Huyber C; Winnicki M; Somers VK
    Chest; 2007 Jan; 131(1):118-21. PubMed ID: 17218564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in mortality of insurance applicants with HIV infection.
    Stout RL; Fulks M; Dolan VF
    J Insur Med; 2012; 43(2):67-75. PubMed ID: 22876410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2014 CRL Build Study of Life Insurance Applicants.
    Fulks M; Dolan VF; Stout RL
    J Insur Med; 2016; 46(1):13-9. PubMed ID: 27562108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation Between Family History of Premature Coronary Artery Disease and the Risk of Death in Patients With Coronary Artery Disease.
    Abdi-Ali A; Shaheen A; Southern D; Zhang M; Knudtson M; White J; Graham M; James MT; Wilton SB
    Am J Cardiol; 2016 Feb; 117(3):353-8. PubMed ID: 26723106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased mortality associated with elevated carcinoembryonic antigen in insurance applicants.
    Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L
    J Insur Med; 2007; 39(4):251-8. PubMed ID: 18522142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum globulin predicts all-cause mortality for life insurance applicants.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2014; 44(2):93-8. PubMed ID: 25816467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study.
    Mehta PK; Johnson BD; Kenkre TS; Eteiba W; Sharaf B; Pepine CJ; Reis SE; Rogers WJ; Kelsey SF; Thompson DV; Bittner V; Sopko G; Shaw LJ; Bairey Merz CN
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age dependent decline of relative risks in life insurance medical underwriting.
    Kneepkens RF; Lindeboom R
    J Insur Med; 2014; 44(3):170-83. PubMed ID: 25622389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-proBNP Predicts All-Cause Mortality in a Population of Insurance Applicants, Follow-up Analysis and Further Observations.
    Fulks M; Kaufman V; Clark M; Stout RL
    J Insur Med; 2017; 47(2):107-113. PubMed ID: 29490161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBCT measured coronary artery calcium scores in asymptomatic life insurance applicants.
    Zamarripa D; Stanger H
    J Insur Med; 2006; 38(4):285-8. PubMed ID: 17323758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality Risk of Low BMI in Life Insurance Applicants.
    Rigatti SJ; Stout R
    J Insur Med; 2024 Jul; 51(1):8-16. PubMed ID: 38802091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical profile and impact of family history of premature coronary artery disease on clinical outcomes of patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial.
    Ertelt K; Généreux P; Mintz GS; Brener SJ; Kirtane AJ; McAndrew TC; Francese DP; Ben-Yehuda O; Mehran R; Stone GW
    Cardiovasc Revasc Med; 2014; 15(8):375-80. PubMed ID: 25288517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.